AARP To Re-Launch “Wise Use” Drug Comparison Campaign In 2006
This article was originally published in The Pink Sheet Daily
The campaign will provide consumers and prescribers with price and effectiveness comparisons for prescription, generic and over-the-counter drugs within the same class. It will be an extension of the group’s 2003 effort.
You may also be interested in...
New site lists median prices and typical price ranges for drugs in nine classes based on prices submitted by AARP Pharmacy Services network pharmacies. Information will eventually be expanded to cover 20 classes of drugs.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.